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Neonatal jaundice is one of the most common reasons for hospital admission in the neonatal unit, and it is 
associated with significant morbidity and mortality. 
 
Objective 
To assess risk factors associated with neonatal jaundice among newborns at a District Hospital in Rwanda. 
 
Methods 
A quantitative approach has been used with a retrospective cross-sectional design. Two hundred and ten files 
were used as sample size. Stratified proportional sampling was used for the years 2016-2018 to select files. 
Data was collected using a structured questionnaire. Descriptive statistics and inferential statistics were used 
for the data analysis.  
 
Results 
The study findings showed that nearly half (44.3%) of 210 newborns were diagnosed with neonatal jaundice. 
The majority (87.2%) was term, and male gender (60.5%). Nearly a third (29.5%) were Low Birth Weight. Signif-
icant risk factors for neonatal jaundice were birth weight (p=0.015), gestational age of the newborn (p=0.002), 
neonatal gender (p=0.004), method of delivery (p=.000), blood group incompatibility (p=0.001); infections (p 
=0.000), cesarean section (p= 0.000) and prematurity (p=0.017). 
 
Conclusion 
There was a high prevalence of neonatal jaundice. Neonatal jaundice risk factors were predominantly 
demographic, maternal and neonatal. Hence there is need to formulate tailored interventions that mitigate 
neonatal jaundice. 
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Neonatal jaundice is a condition that affects 60%-
80% of newborns worldwide.[1] Though most 
neonates experience mild jaundice, a Global Burden 
of Disease (GBD) study in 2016 showed that 
neonatal jaundice accounted for 1,008 deaths per 
100,000 live births and ranked seventh in mortality 
during the early-neonatal period (0 – 6 days).[2] 
Severe hyperbilirubinemia is estimated to affect 1.1 
million neonates every year in South Asia and sub-
Saharan Africa (SSA), where it is ranked the 7th and 
eighth leading cause of neonatal mortality, 
respectively.[3] In South Africa, the prevalence of 
neonatal jaundice was 55.2%,[1] whereas, in 
Pakistan, the prevalence of neonatal jaundice was 
27.6%.[4]  
 
Severe hyperbilirubinemia, with or without 
encephalopathy, is associated with substantial 
mortality and long-term morbidity in low-to-
moderate income countries (LMIC),[5] including 
Rwanda. High levels of bilirubin can cause 
permanent brain damage (kernicterus), and 
therefore screening and prompt treatment are 
important strategies.[5] At three years of age, full 
neurological symptoms of kernicterus, including 




bilateral athetosis with involuntary muscular 
spasms, extrapyramidal symptoms, seizure, mental 
retardation, dysarthria, high-frequency hearing 
loss, and strabismus and eye movement 
abnormalities can appear.[5] 
 
Another study conducted on the magnitude of 
neonatal jaundice and in a NICU in Mekelle City 
Public Hospitals, Northern Ethiopia, revealed that 
risk factors such as prolonged duration of labor, 
male neonates, and "O" blood group was associated 
with neonatal jaundice.[6] A study conducted 
hyperbilirubinemia in newborns in Kaiser 
Permanente Northern California showed that boys, 
nonwhite, large for gestational age, and of lower 
gestational age were associated with neonatal 
jaundice.[7] 
 
Rwanda Health Sector has registered significant 
achievements in the previous years. However, 
challenges need to be addressed to improve the 
quality of service delivery for the prevention and 
control of some conditions. The identification of 
needs and a concerted effort to improve 
management at different levels of the health system 
can significantly reduce acute bilirubin 
encephalopathy (ABE) and improve opportunities 
for thousands of newborns around the world.[8] 
Rwanda, as one of the LMIC, needs to know the  
prevalence and risk factors associated with neonatal 
jaundice to reinforce the existing policies in 
maternal and neonatal child health. Risk factors 
like maternal, prenatal, and neonatal are 
significantly or not significantly associated with 
severe hyperbilirubinemia in LMIC.[9] 
 
Several studies have identified factors associated 
with neonatal jaundice. A study conducted in Iran 
addressed the complications of neonatal jaundice 
and predisposing factors in newborns with 
idiopathic jaundice, ABO incompatibility, Rh 
incompatibility, and G6PD deficiency as risk 
factors.[5] A study in Southern Nepal indicated that 
male gender, high birth weight, breastfeeding, warm 
ambient temperature, primiparity, skilled birth 
attendance, place of delivery, prolonged labor, oil 
massage, paternal education, and ethnicity were 
critical risk factors.[10] However, data about the 
prevalence and related risk factors in Rwanda are 
limited.[3] 
 
In Rwanda, the only study conducted at Ruhengeri 
district hospital identified a high prevalence of 
neonatal jaundice, which was 41.3%, and the risk 
factors of pathologic hyperbilirubinemia in the same 
hospital were maternal age, birth weight and the 
number of parity.[3] The author of the only research 
conducted on neonatal jaundice in Rwanda 
recommended that other research studies should be 
conducted across the country to confirm the 
prevalence of pathologic hyperbilirubinemia in 
newborns. The present study assessed the 
prevalence and risk factors associated with neonatal 





A retrospective design was used to collect data from 
the files of newborns admitted in the neonatal unit 
of Kabgayi District Hospital in Muhanga District 
during 2016-2018. The study was conducted 
between 05 March and 31 May 2019. 
 
Study setting 
The study was conducted in the neonatology ward 
at Kabgayi District Hospital in the Southern 
Province, Muhanga District. The setting was 
selected as it had over a dozen cases of neonatal 
jaundice admitted in the neonatal unit in a two-
week period. 
 
Inclusion and exclusion criteria 
The inclusion criteria were all newborns born and 
later readmitted to the neonatal unit of Kabgayi 
District Hospital in Muhanga District during 2016-
2018. Exclusion criteria were newborns admitted 




The formula of Taro Yamane (1967) to calculate the 
sample size of newborns for representing all 
newborns admitted to the hospital has been used. 
n= N/1+N*(e) 2 where n= Sample size; n= the 
population size; e= the acceptable sampling error 
(e=0.05). The population of this study included 160 
newborns in 2016, 157 in 2017, and 125 in 2018 
for a total population of 442. The sample size was 
442/1+442*(0.05)2 = 210 newborns. 
 
Sampling strategy 
A stratified proportional sampling for newborns 
born and readmitted at the hospital in 2016- 2018. 
  
Measures 
A modified data collection tool from Brits et al 
(2018), who conducted a similar study on the 
prevalence of neonatal jaundice and risk factors in 
healthy term neonates [1], has been used with 
permission to collect data needed to answer the 
research questions. The tool was modified and 
adapted to the Rwandan context, with the removal 




of the mother's race and the primiparity. Other 
items on the tool have been maintained, as they 
were applicable in the Rwandan context. The data 
collection tool had two sections: 
 
Section 1: Demographic data of the newborn and 
mother (4 items) - maternal age (years), neonatal 
gender, birth weight (grams), age of admission to the 
neonatal unit (days) and participants medical 
diagnosis.  
Section 2: Risk factors of the mother (7 items) and 
neonate (10 items). Maternal - labor induction with 
oxytocin, premature rupture of membranes (PROM), 
delivery method, and oral contraceptive use in 
pregnancy, alcohol use in pregnancy, sibling 
jaundice, and ABO incompatibility. Neonatal – 
prematurity, gestational age (weeks), not 
breastfeeding ≤ hour post-birth, ABO, and other 
blood group incompatibilities, infection, 
cephalohematoma, and early hospital discharge.  
 
Validity and reliability of the data collection 
tool 
The tool was submitted to an expert nurse with Doc-
torate in Nursing Practitioner (DNP) in neonatology 
science for a face validation to confirm if the tool 
would be measuring what it was supposed to meas-
ure (the prevalence and risk factors of neonatal 
jaundice). The tool was piloted on 10 cases admitted 
in the neonatal unit in 2018. For this study, 
Cronbach's alpha has been used to determine inter-
nal consistency. The tool had 22 items, and the 
Cronbach‘s alpha test was 0.856 meaning the in-
strument was a very good measure of concepts un-
der study.  
 
Data collection  
After the permission of the University of Rwanda 
and the district hospital, the investigator reviewed 
the births recorded in the 2016 -2018 neonatal files. 
The information was retrieved from the neonatal 
files in the registry of the hospital. 
 
Data analysis 
Data were analyzed using SPSS software version 23. 
The data analysis used descriptive statistics in the 
form of percentages and frequencies was used to 
describe the demographic data of the child and the 
mother, the maternal and neonatal risk factors. Chi-
square test was used to establish any association 
between demographics, neonatal, and maternal risk 
factors and neonatal jaundice. A p-value of < 0.05 
was statistically significant. 
 
Ethical considerations 
An ethical clearance from the University of Rwanda, 
College of Medicine and Health Sciences, 
Institutional Review Board (IRB), and the 
recommendation from the Ministry of Health (MOH) 
was obtained. The approval from the study site had 





Table 1 displays results on maternal age, gender, 
birth weight, and postnatal age.  
 
 
Table 1. Demographic data of mother and newborn (n=210) 
Demographic variables of the baby  frequency Percentage 
New-born age of admission in 
neonatal unit(days) 
≤7days 176 83.8% 
˃7days 34 16.2 % 
Total 210 100% 
Gender female 83 39.5% 
male 127 60.5% 
Total 210 100% 






2001g-2500g 62 29.5% 
2501g-3000g 147 70% 




Table 1 shows demographic data of neonates. The majority (83.8%) of neonates were less or equal 
to 7 days and 16.2% with more than 7 days. There were 127 (60.5%) males and 83 (39.5%) 




females. For the birth weight, the majority range of weight for 210 participants was 2501g-3000g 
147 (70%), 1 (0.5%) was in the range of 1501g-2000g of birth weight, and 62 (29.5%) were in the 





















Figure 1. Prevalence of neonatal jaundice 
 
An analysis of the participants' medical diagnosis in Figure 1 indicated that the majority of 
participants, 93 (44.3%) were presenting with neonatal jaundice, 23(11.0%), infection, 30(14.3%) 
birth asphyxia, 28(13.3%) prematurity, 11(5.2%) respiratory distress syndrome, 7(3.3%) 
congenital malformation, 4(1.9%) LBW, 1(0.5%) hypoglycaemia, 1(0.5%) bleeding disorders, 
1(0.5%) neurologic disorders, 1(0.5%) dehydration, 1(0.5%) and renal problems. Therefore, the 










































Maternal risk factors of neonatal jaundice 
Table 2. Maternal risk factors of neonatal jaundice (n=210)   
 
Variables frequency Percentage 
Maternal age   15-24 
                       25-34  



















No 210 100% 
Total 210 100% 
 










Total 210 100% 
Oral contraceptive in pregnancy Yes 0 0% 
No 210 100% 
Total 210 100% 
Alcohol use during pregnancy Yes 0 0% 
No 210 100% 
Total 210 100% 
Sibling jaundice Yes 0 0% 
No 210 100% 
Total 210 100% 
ABO incompatibility Yes 3 1.4% 
No 207 98.6% 
Total 210 100% 
premature rupture of membranes Yes 1 0.5% 
No 209 99.5% 
Total 210 100% 
 
Table 2 shows results on the maternal risk factors of neonatal jaundice. For the method of 
delivery, the majority of mothers 106 (50.5%) delivered by cesarean; 104 (49.5%) delivered by 
natural method. For ABO incompatibility, only 3 (1.4%) of mothers were presenting ABO 
incompatibility. For premature rupture of membranes, only one mother, 1 (0.5%) had 
experienced the premature rupture of membranes. 





ABO and other 
blood group 
incompatibilities 
No 200 95.2% 
Yes 10 4.8% 
Total 
210 100.0% 
Infections No 160 76.2% 




Yes 50 23.8% 
Total 210 100.0% 
Prematurity No 164 78.1% 
Yes 46 21.9% 
Total 210 100.0% 
gestation age of the 
baby(weeks) 
28 3 1.4% 
30 3 1.4% 
31 2 1.0% 
32 9 4.3% 
33 1 0.5% 
34 4 1.9% 
35 6 2.9% 
36 15 7.1% 
37 9 4.3% 
38 26 12.4% 
39 62 29.5% 
40 62 29.5% 
41 8 3.8% 
Total 210 100.0% 
non breastfeeding 
within one hour 
after birth 
No 199 94.8% 
Yes 11 5.2% 
Total 210 100.0% 
Early hospital 
discharge 
No 199 94.8% 
Yes 11 5.2% 
Total 210 100.0% 
Cephalohematoma No 209 99.5% 
Yes 1 0.5% 
Total 210 100.0% 
 
Table 3 displays the neonatal risk factors of 
jaundice. For ABO and other blood group 
incompatibilities, the majority [200 (95.2%)] 
were not presenting it. A significant number 
of new- borns160 (76.2%) did not present 
with any kind of infection. Approximately 46 
(21.9%) presented with prematurity and 164 
(78.1%) were not. For gestation age of the 
baby (weeks), 3 (1.4%) were having 28 
weeks, 3 (1.4%) were having 30 weeks, 2 
(1.0%) were having 31 weeks, 9 (4.3%) were 
having 32 weeks, 1  (0.5%) was having 33 
weeks, 4(1.9%) were having 34 weeks, 6 
(2.9%) were having 35 weeks, 15 (7.1%) were 
having 36 weeks, 9 (4.3%) were having 37 
weeks, 26 (12.4) were having 38 weeks, 62 
(29.5%) were having 39 weeks, 62 (29.5%) 
were having 40 weeks, 8 (3.8%) were having 
41 weeks. For non-breastfeeding within one 
hour after birth, 11 (5.2%) were able to 
breastfeed within one hour after birth, and 
199 (94.8%) were not. For early hospital 
discharge, 11 (5.2%) have been early 
discharged, and 199 (94.8%) were not. For 
cephalohematoma, 1 (0.5%) newborn was 
presenting it, and 209 (99.5%) were not. 
 
 
Risk Factors Associated with Neonatal 
Jaundice 
  Table 4 displays the association between 
maternal and neonatal risk factors with 
neonatal jaundice. Demographic factors 
associated with neonatal jaundice were birth 
weight (p = 0.015) and neonatal gender 
(p=0.004). Regarding maternal risk factors, 
there was a significant association between 
the method of delivery (p= 0.000) and 
neonatal jaundice. For neonatal risk factors, 
factors with significant associations were 
gestational age of the new born (p= .002), 
ABO and other blood group incompatibilities 
(p= 0.001), infections (p= 0.000) and 
prematurity (p= 0.017).  
 
 




Table 4. Factors associated with neonatal Jaundice (N= 210) 
Characteristics Presence of jaundice No jaundice P value 
                                                            Demographic characteristics of neonates 
Number of days of the new-born admitted in 
neonatal unit 
   
 
.150 1 to 7 days 76(36%) 100(48%) 
Less than 7 days 17(8%) 17(8%) 
Neonatal Gender    
.004 
 
Female 41(19%) 42(20%) 
 Male 52(25%) 75(36%) 
Birth weight    
1501 to 2000g 0 (0) 1(0.5%)  
.015 2001 to 2500g 16 (8%) 46 (22%) 
2501 to 3000g 77 (37%) 70 (33%) 
Maternal risk factors 
Maternal age    
15 to 24 years 14 (7%) 32 (15%)  
.255 25 to 34 years 62(30%) 69 (33%) 
35 years and greater 17 (8%) 16 (8%) 
Method of Delivery    
Natural 32 72 .000 
C section 61 45 
ABO incompatibilities    
Yes 3 (1.4%) 0 (0%) .147 
No 90(43%) 117 (56%) 
Premature rupture of membranes    
Yes 1 (0.5%) 0(0%) .532 
No 92(44%) 117(56%) 
Neonatal risk factors 
Gestation age of the new-born    
 
.002 
28 to 32weeks 2(1%) 15(7%) 
33 to 36 weeks 8(4%) 18(9%) 
More than 37 weeks 83(39%) 84(40%) 
    
 Infections    
Yes 37 (18%) 13 (6%) .000 
No 56 (27%) 104 (49%) 
Prematurity    
Yes 12(6%) 34(16%) .017 
No 81(38%) 83(40%) 
Non breastfeeding within one hour    
Yes 5(2%) 6(3%) .858 
No  88(42% 111(53%) 
ABO and other blood group incompatibilities    
Yes 10 (5%) 0 (0%) .001 
No 83 (39%) 117 (56%) 
Early Hospital discharge    
Yes a2 (1%) 9(4%) .107 
No 91(42%) 108(51%) 
 Presence of cephalohematoma    
Yes 0(0) 1 .505 
No 93(44%) 116(55%) 






The prevalence of neonatal jaundice was high as 
evidenced with 44.3% of newborns developing 
neonatal jaundice. The present study was in 
contrast to what has been found in the study 
conducted in Nigeria on the prevalence of neonatal 
jaundice in Eku Baptist community Hospital in 
Delta State, which showed that 70.5% of newborns 
developed neonatal jaundice within the first week of 
life.[11] For the gender, among jaundiced neonates, 
according to the cross-tabulation, males constituted 
a high number 127 (60.5%) . Males were higher in 
number than females. This finding shows that male 
infants are more susceptible to neonatal jaundice 
than female infants in the present study, in contrast 
to a study in Ibadan, which found that jaundiced 
female infants were presenting a significantly higher 
number (53.9%) than male infants.[12] Similarly to 
the study conducted in Nigeria on the of neonatal 
jaundice in a Community Hospital in Delta State 
showed that male newborns presented in higher 
numbers 67.4% with jaundice than females.[11] 
 
This finding is similar to a study on the incidence, 
risk factors, and outcome of G6PD among newborns 
presenting with hyperbilirubinemia in a tertiary 
care hospital in Punjab, which found jaundice was 
more prevalence in male infants 68.45% than 
female infants.[13] For the birth weight, the majority 
of jaundiced neonates were 2501g-3000g 147(70%). 
This finding is similar to a study at Ruhengeri 
Hospital in Rwanda, which showed that the majority 
(72%) of jaundiced newborns were higher than 2500 
g at birth.[3] 
 
Risk factors associated with neonatal jaundice 
Birth weight, neonatal gender, ABO and other blood 
group incompatibilities, infections, prematurity, 
gestation age of the baby and the C/Section as a 
method of delivering were predominant associated 
risk factors with neonatal jaundice. Almost the 
same risk factors have been found in the study 
conducted in Nigeria in the Eku Baptist Community 
Hospital in Delta State, which showed that neonatal 
jaundice is related to sepsis, anemia, prematurity, 
ABO incompatibility and lack of breastfeeding.[11] 
A study conducted on the magnitude of neonatal 
jaundice and its associated factor in NICUs in 
Mekelle City Public Hospitals in Northern Ethiopia, 
infections were associated with neonatal 
jaundice.[6] 
 
A study conducted in a tertiary care hospital in 
India indicated prematurity was associated with 
neonatal jaundice,[14] and septicemia. Similarly, a 
study in the Federal Medical Centre Abakaliki, 
Southeast Nigeria.[15] A study conducted on 
heliotherapy for neonatal hyperbilirubinemia in 
Southwest, Nigeria, blood incompatibility was 
associated with severe neonatal jaundice.[17] A 
study conducted on when babies turn yellow in 
Singapore, found liver disease, bruising, and 
metabolic disorders were associated with neonatal 
jaundice.[15] In Iran, a study found idiopathic 
jaundice, ABO incompatibility, Rh incompatibility, 
and G6PD deficiency as risk factors associated with 
neonatal jaundice.[5] A study in Southern Nepal 
showed that male sex, LBW, breastfeeding patterns, 
warm ambient temperature, primipara, skilled birth 
provider, place of delivery, prolonged labor, oil 
massage, paternal education, and ethnicity were 
critical risk factors.[10] At the National District 
Hospital in Bloemfontein, normal vaginal delivery 
was the only risk factor associated with neonatal 
jaundice.[1] 
 
In contrast, a study conducted on risk factors for 
severe neonatal hyperbilirubinemia in LMIC showed 
that risk factors such as race, social class, 
primiparity, sibling treated for jaundice, LBW, and 
weight loss associated with severe neonatal 
jaundice.[9] In contrast, risk factors for Malaysian 
neonates included gender, birth weight, and 
gestation age of neonates were not associated with 
neonatal jaundice.[16] The study conducted on 
pregnancy obesity associated with 
hyperbilirubinemia in neonates with a high 
prevalence in Hawaiians and Pacific Island women, 
showed that obesity in pregnancy is associated with 
neonatal jaundice.[17] In the study conducted on 
the burden and management of neonatal jaundice 
in Nigeria, G6PD deficiency was a significant risk 
factor associated with neonatal jaundice.[20] 
 
Limitations 
As the study was retrospective for only admitted 
newborns in the neonatal unit in 2016-2018, it 
cannot be generalized to other areas. The 
investigator had many challenges with incomplete, 
missing, and inaccurate documentation in the NICU 
registers and neonatal files. The poor record-
keeping was a big problem with the files. For 
example, the blood group of the mother and 
newborn were absent, the time of membrane 
rupture was missing in files, and the time of yellow 
color occurrence was missing in most of the files. 
Other information, such as the use of contraception 










ABO and other blood group incompatibilities, 
infections, prematurity, gestational age of the baby, 
and the cesarean as a method of delivery were 
predominant associated risk factors with neonatal 
jaundice. There is a need for conducting further 
research on prevalence and risk factors associated 
with neonatal jaundice in other districts of Rwanda 
as it remains a challenge. Health care providers who 
work with neonates should play an essential role in 
identifying risk factors associated with neonatal 
jaundice on time and prevent their occurrence 
where possible. Health education is vital for the 
parents for the early detection of neonatal jaundice. 
Regular antenatal care must be done for all 
pregnant women, and the extended stay in the 
hospital after newborn birth can play an essential 
role in preventing neonatal jaundice. There must be 
more training of health care providers, especially 
nurses and midwives, in early diagnosis of the risk 
factors of neonatal jaundice. Guidelines and 
protocols about neonatal jaundice must be available 
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